European Union flag with twelve yellow stars on a blue background, representing EU regulations and regulatory compliance.

Successfully Registering 25 Medical Devices in EUDAMED

Through expert regulatory guidance, a structured approach, and the identification of documentation gaps, Obelis helped the UK-based manufacturer navigate the registration process, improve the completeness of its device information, and meet its European regulatory requirements.

Novel Foods: When is an ingredient too new for the EU market? 

Under Regulation (EU) 2015/2283, a novel food is generally a food that was not consumed to a significant degree within the European Union before 15 May 1997 and falls within one of the categories defined by the legislation.

Business professionals reviewing documents and working on laptops during a meeting, representing regulatory consulting and compliance advisory services.

Supporting Regulatory Progress for Class IIb X-Ray Systems

Discover how Obelis supported Bemems Co., Ltd., a South Korean medical device manufacturer, in advancing its European regulatory compliance for Class IIb X-ray systems. Building on a successful collaboration involving EUDAMED registration and regulatory documentation, Obelis assisted the company in obtaining a European Authorised Representative (EAR) Certificate.

Magnifying glass highlighting a completed checklist on a notebook, representing regulatory compliance audits, document reviews and quality assessments.

A Smooth Path to EU and UK Cosmetic Markets

Discover how Obelis supported Harsoria Healthcare in expanding its Class IIa medical device portfolio into Switzerland. From reviewing the applicable Swiss regulatory requirements to supporting registration in swissdamed, Obelis helped ensure a smooth and well-organized market entry process.

Switzerland highlighted with a map pin representing Swiss market access and regulatory compliance.

Extending Medical Device Compliance to the Swiss Market

Discover how Obelis supported Harsoria Healthcare in expanding its Class IIa medical device portfolio into Switzerland. From reviewing the applicable Swiss regulatory requirements to supporting registration in swissdamed, Obelis helped ensure a smooth and well-organized market entry process.